Michael C. Donegan, CAO and VP of Finance at TherapeuticsMD, Inc. (TXMD), sold 29,790 shares at $0.54 ($16K) on 2021-11-30, disclosed to the SEC on 2021-12-02.
Open-market sale of $16k TXMD by CAO and VP of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TXMD | SELL | 2022-12-09 | $4K | — | Filing → |
| TXMD | SELL | 2021-05-12 | $5K | — | Filing → |